Does IMATINIB Cause Therapeutic product effect incomplete? 109 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Therapeutic product effect incomplete have been filed in association with IMATINIB (Imatinib). This represents 0.3% of all adverse event reports for IMATINIB.
109
Reports of Therapeutic product effect incomplete with IMATINIB
0.3%
of all IMATINIB reports
4
Deaths
10
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From IMATINIB?
Of the 109 reports, 4 (3.7%) resulted in death, 10 (9.2%) required hospitalization, and 5 (4.6%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which IMATINIB Alternatives Have Lower Therapeutic product effect incomplete Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL